Leitlinie
Guidelines for biomimetic 3D/4D printing in drug delivery
Materials Chemistry and Physics · 2024-10 · 325 · 129692
DOI: 10.1016/j.matchemphys.2024.129692 ↗Kurz gefasst
Leitlinie in der Zeitschrift Materials Chemistry and Physics, 2024-10. Verfasst von Moataz Dowaidar. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 106 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Dowaidar, M. (2024). Guidelines for biomimetic 3D/4D printing in drug delivery. Materials Chemistry and Physics, 325, 129692. https://doi.org/10.1016/j.matchemphys.2024.129692
Vancouver
Dowaidar M. Guidelines for biomimetic 3D/4D printing in drug delivery. Materials Chemistry and Physics. 2024;325:129692. doi:10.1016/j.matchemphys.2024.129692
BibTeX
@article{Dowaidar2024,
author = {Dowaidar, Moataz},
title = {Guidelines for biomimetic 3D/4D printing in drug delivery},
journal = {Materials Chemistry and Physics},
year = {2024},
volume = {325},
pages = {129692},
doi = {10.1016/j.matchemphys.2024.129692}
}
EUVIMED